Advertisement

Clinical Rheumatology

, Volume 26, Issue 9, pp 1537–1539 | Cite as

Pulmonary aneurysms and intracardiac thrombi due to Behçet’s disease in an African-American adolescent with oculocutaneous albinism

  • Lois M. Endo
  • Steven M. Rowe
  • Robb L. Romp
  • Mark A. Buckmaster
  • T. Prescott Atkinson
Case Report

Abstract

Behçet’s disease (BD) is a systemic vasculitis that may involve a variety of organs. We describe a girl with oculocutaneous albinism (OCA) who, on initial evaluation for popliteal artery occlusion, was noted to have multiple cardiac thrombi. She later developed hemoptysis, which was the result of bilateral pulmonary artery aneurysms. Her clinical picture was consistent with BD. She was initially treated with prednisone and cyclophosphamide, followed by maintenance therapy with infliximab. This case describes a unique patient with OCA who developed BD with large pulmonary aneurysms and has remained stable for over 1 year while receiving infliximab.

Keywords

Albinism Behçet’s disease Infliximab Vasculitis 

References

  1. 1.
    Kurokawa S, Suzuki N (2004) Behçet’s disease. Clin Exp Med 4:10–20CrossRefGoogle Scholar
  2. 2.
    Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291PubMedCrossRefGoogle Scholar
  3. 3.
    Krause I, Uziel Y, Guedj D, Mukamel M, Harel L, Molad Y, Weinberger A (1999) Childhood Behçet’s disease: clinical features and comparison with adult-onset disease. Rheumatol 38:457–461CrossRefGoogle Scholar
  4. 4.
    International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080Google Scholar
  5. 5.
    Azizlerli G (2005) Juvenile Behçet’s syndrome. In: Cassidy J, Petty R (eds) Textbook of pediatric rheumatology. Elsevier Saunders, PhiladelphiaGoogle Scholar
  6. 6.
    Koné-Paut L, Yudakul S, Bahabri S, Shafae N, Ozen S, Ozdogan H, Bernard J (1998) Clinical features of Behçet’s disease in children: an international collaborative study of 86 cases. J Pediatr 132:721–725PubMedCrossRefGoogle Scholar
  7. 7.
    Leiba M, Seligsohn U, Sidi Y, Harats D, Sela BA, Griffin JH, Livneh A, Rosenberg N, Gelernter I, Gur H, Ehrenfeld M (2004) Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease. Ann Rheum Dis 63:1445–1449PubMedCrossRefGoogle Scholar
  8. 8.
    Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behçet’s disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRefGoogle Scholar
  9. 9.
    Erkan F, Kiyan E, Tunaci A (2002) Pulmonary complications of Behçet’s disease. Clin Chest Med 23:493–503PubMedCrossRefGoogle Scholar
  10. 10.
    Azteni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani S (2005) Behçet’s disease and cardiovascular involvement. Lupus 14:723–726CrossRefGoogle Scholar
  11. 11.
    Connolly M, Armstrong JS, Buckley DA (2005) Infliximab treatment for severe orogenital ulceration in Behçet’s disease. Br J Rheumatol 153:1073–1075Google Scholar
  12. 12.
    Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gul A (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease: an open-label trial. Arthritis Rheum 52:2478–2484PubMedCrossRefGoogle Scholar
  13. 13.
    Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of long-standing neuro-Behçet’s disease with infliximab. J Rheumatol 32:181–183PubMedGoogle Scholar
  14. 14.
    Wechsler B, Sable-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O et al (2004) Infliximab in refractory uveitis due to Behçet’s disease. Clin Exp Rheumatol 22(Suppl 34):S14–S16PubMedGoogle Scholar
  15. 15.
    Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S et al (2004) Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitis. J Rheumatol 31:1362–1368PubMedGoogle Scholar
  16. 16.
    Saulsbury F, Mann J (2003) Treatment with infliximab for a child with Behçet’s disease. Arthritis Rheum 49:599–600PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2006

Authors and Affiliations

  • Lois M. Endo
    • 1
  • Steven M. Rowe
    • 1
  • Robb L. Romp
    • 1
  • Mark A. Buckmaster
    • 1
  • T. Prescott Atkinson
    • 1
    • 2
  1. 1.Department of PediatricsUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Children’s Hospital, CHT752MBirminghamUSA

Personalised recommendations